VirginiaHarrodMDPhD

Pediatric Hematology & Oncology • Austin, TX

Pediatric Hematologic Oncology, Pediatric Neuro-Oncology

Director Pediatric Neuro-Oncology Program

Join to view full profile

Dr. Harrod is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Harrod's full profile

Already have an account?

Office
4910 Mueller Blvd Suite 200
Austin, TX 78723
Phone+1 512-628-1900

Education & Training

University of TennesseeFellowship, Pediatric Hematology/Oncology, 2004 - 2007
University of Texas at Austin Dell Medical SchoolResidency, Pediatrics, 2001 - 2004
McGovern Medical School at UTHealthClass of 2001

Certifications & Licensure

TX State Medical License 2006 - 2026
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy Start of enrollment: 2015 Sep 01
Recruiting
Phase 2
Neuroblastoma Maintenance Therapy Trial Start of enrollment: 2016 Feb 01
Recruiting
Phase 2
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH) Start of enrollment: 2016 Mar 07
Recruiting
Phase 3
Roles: Principal Investigator, Contact

Publications & Presentations

PubMed

3 citations
Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial.
Giselle L Saulnier Sholler, Genevieve Bergendahl, Elizabeth C Lewis, Jacqueline Kraveka, William Ferguson
Genome Medicine. 2024-02-12
8 citations
Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study.
Craig Erker, Martin Mynarek, Simon Bailey, Claire M Mazewski, Lorena Baroni
Journal of Clinical Oncology. 2023-04-01
3 citations
A pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastoma.
Jacqueline M Kraveka, Elizabeth C Lewis, Genevieve Bergendahl, William Ferguson, Javier Oesterheld
Cancer Reports. 2022-11-01

Press Mentions

A Texas Miracle: 11-Year-Old’s Inoperable, Deadly Brain Tumor Miraculously DissaperasOctober 5th, 2019
Report: Kuwaiti Child Gets Life-Changing Surgery to Remove Huge TumorAugust 25th, 2019
Doctors Baffled When 11-Year-Old Girl’s Inoperable Brain Tumor Miraculously DisappearsJanuary 7th, 2019
Join now to see all